Lipocine
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $190 | $119 | $1,145 | $114 |
Gross Profit | 190 | 104 | 1,130 | 114 |
EBITDA | -2,607 | -3,657 | -2,357 | -3,170 |
EBIT | -2,622 | -3,671 | -2,370 | -3,186 |
Net Income | -2,622 | -3,671 | -2,370 | -3,186 |
Net Change In Cash | 190 | 119 | 1,145 | 114 |
Free Cash Flow | -3,028 | -2,257 | -2,919 | -2,985 |
Cash | 4,979 | 5,015 | 5,205 | 3,901 |
Basic Shares | 8,216 | 6,795 | 5,708 | 5,413 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,976 | $11,198 | $-2,850 | $500 |
Gross Profit | -6,607 | 11,198 | -13,026 | -8,056 |
EBITDA | -9,566 | 50 | -16,322 | -10,721 |
EBIT | -9,627 | 9 | -16,351 | -10,730 |
Net Income | -9,627 | 8 | -16,352 | -10,758 |
Net Change In Cash | 1,976 | 11,198 | -2,850 | 500 |
Free Cash Flow | -9,760 | -1,311 | -11,879 | -12,102 |
Cash | 5,205 | 6,205 | 4,771 | 3,148 |
Basic Shares | 5,708 | 5,422 | 5,269 | 5,256 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.32 |
2026-03-31 | -$0.54 |
2025-12-31 | -$0.42 |
2025-09-30 | -$0.59 |